RGTA-4131®, an analogue of heparan sulfate, is a potential novel protective and regenerative therapy for ischemic stroke - Normandie Université Access content directly
Conference Papers Year :
No file

Dates and versions

hal-02269678 , version 1 (23-08-2019)

Identifiers

  • HAL Id : hal-02269678 , version 1

Cite

Y Khelif, Ms Quittet, J Toutain, D Divoux, F Sineriz, et al.. RGTA-4131®, an analogue of heparan sulfate, is a potential novel protective and regenerative therapy for ischemic stroke. Congrès de la section 28 du CNRS « Pharmacologie, Bio-ingenierie, imagerie, biotechnologie », Jun 2016, Bordeaux, France. ⟨hal-02269678⟩
26 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More